ICU Medical CL2000S-10Recalls & reported problems
Icu Medical, Inc. · ChemoLock™, 10 Units · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00887709071735), received between Mar 3, 2021 and Aug 18, 2022 — classified as 6 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (6 reports).
60 other recalls cover devices cleared under the same FDA submission (K131549); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Fluid/Blood Leak6
Patient problems
- Chemical Exposure6
- No Clinical Signs, Symptoms or Conditions6
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 18, 2022Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT OCCURRED ON AN UNSPECIFIED DATE AND INVOLVED A CHEMOLOCK PORT, WHERE A MEDWATCH REPORT WAS FILED. THE REPORTER WHO ELECTED TO NOT BE IDENTIFIED STATED DEVICE BROKE, SPILLING HAZARDOUS CHEMOTHERAPY MEDICATION WITH EMPLOYEE EXPOSURE. THERE WAS NO PATIENT INVOLVEMENT, HOWEVER THE CUSTOMER STATED AN UNSPECIFIED HARM DUE TO HAZARDOUS CHEMOTHERAPY MEDICATION WITH EMPLOYEE EXPOSURE.
Patient problems: Chemical Exposure; No Clinical Signs, Symptoms or Conditions
MAUDE report 15250263 ↗MalfunctionMar 3, 2021Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT OCCURRED AT 5:00PM AT THE PATIENT¿S HOME AND INVOLVED AN ISSUE WITH A CHEMOLOCK AND CHEMOLOCK PORT AND AN UNPROMPTED DISCONNECT OF THE AMBULATORY PUMP RESULTING IN UNPROTECTED CHEMO EXPOSURE TO DOXORUBICINE. IT WAS REPORTED THAT THE DEVICE WAS IN USE AN HOUR WHEN A DROPLET WAS NOTED AND THERAPY WAS HALTED. THE SET UP WAS A PIGGYBACK AND THERE WERE NO ISSUES NOTED DURING INITIAL SET-UP/PRIMING. THERE IS PATIENT INVOLVEMENT, AND ALTHOUGH THERE WAS A REPORT OF A DELAY IN THERAPY, THERE WAS NO ADVERSE EVENT AND NO ONE WAS HARMED AS A RESULT OF THE REPORTED EVENT. THIS REPORT REFLECTS THE FOURTH OF FIVE EVENTS REPORTED.
Patient problems: Chemical Exposure; No Clinical Signs, Symptoms or Conditions
MAUDE report 11407816 ↗MalfunctionMar 3, 2021Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT OCCURRED AT 5:00PM AT THE PATIENT¿S HOME AND INVOLVED AN ISSUE WITH A CHEMOLOCK AND CHEMOLOCK PORT AND AN UNPROMPTED DISCONNECT OF THE AMBULATORY PUMP RESULTING IN UNPROTECTED CHEMO EXPOSURE TO DOXORUBICINE. IT WAS REPORTED THAT THE DEVICE WAS IN USE AN HOUR WHEN A DROPLET WAS NOTED AND THERAPY WAS HALTED. THE SET UP WAS A PIGGYBACK AND THERE WERE NO ISSUES NOTED DURING INITIAL SET-UP/PRIMING. THERE IS PATIENT INVOLVEMENT, AND ALTHOUGH THERE WAS A REPORT OF A DELAY IN THERAPY, THERE WAS NO ADVERSE EVENT AND NO ONE WAS HARMED AS A RESULT OF THE REPORTED EVENT. THIS REPORT REFLECTS THE THIRD OF FIVE EVENTS REPORTED.
Patient problems: Chemical Exposure; No Clinical Signs, Symptoms or Conditions
MAUDE report 11407810 ↗MalfunctionMar 3, 2021Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT OCCURRED AT 5:00PM AT THE PATIENT¿S HOME AND INVOLVED AN ISSUE WITH A CHEMOLOCK AND CHEMOLOCK PORT AND AN UNPROMPTED DISCONNECT OF THE AMBULATORY PUMP RESULTING IN UNPROTECTED CHEMO EXPOSURE TO DOXORUBICINE. IT WAS REPORTED THAT THE DEVICE WAS IN USE AN HOUR WHEN A DROPLET WAS NOTED AND THERAPY WAS HALTED. THE SET UP WAS A PIGGYBACK AND THERE WERE NO ISSUES NOTED DURING INITIAL SET-UP/PRIMING. THERE IS PATIENT INVOLVEMENT, AND ALTHOUGH THERE WAS A REPORT OF A DELAY IN THERAPY, THERE WAS NO ADVERSE EVENT AND NO ONE WAS HARMED AS A RESULT OF THE REPORTED EVENT. THIS REPORT REFLECTS THE FIFTH OF FIVE EVENTS REPORTED.
Patient problems: Chemical Exposure; No Clinical Signs, Symptoms or Conditions
MAUDE report 11407799 ↗MalfunctionMar 3, 2021Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT OCCURRED AT 5:00PM AT THE PATIENT¿S HOME AND INVOLVED AN ISSUE WITH A CHEMOLOCK AND CHEMOLOCK PORT AND AN UNPROMPTED DISCONNECT OF THE AMBULATORY PUMP RESULTING IN UNPROTECTED CHEMO EXPOSURE TO DOXORUBICINE. IT WAS REPORTED THAT THE DEVICE WAS IN USE AN HOUR WHEN A DROPLET WAS NOTED AND THERAPY WAS HALTED. THE SET UP WAS A PIGGYBACK AND THERE WERE NO ISSUES NOTED DURING INITIAL SET-UP/PRIMING. THERE IS PATIENT INVOLVEMENT, AND ALTHOUGH THERE WAS A REPORT OF A DELAY IN THERAPY, THERE WAS NO ADVERSE EVENT AND NO ONE WAS HARMED AS A RESULT OF THE REPORTED EVENT. THIS REPORT REFLECTS THE SECOND OF FIVE EVENTS REPORTED.
Patient problems: Chemical Exposure; No Clinical Signs, Symptoms or Conditions
MAUDE report 11407755 ↗MalfunctionMar 3, 2021Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT OCCURRED AT 5:00PM AT THE PATIENT¿S HOME AND INVOLVED AN ISSUE WITH A CHEMOLOCK AND CHEMOLOCK PORT AND AN UNPROMPTED DISCONNECT OF THE AMBULATORY PUMP RESULTING IN UNPROTECTED CHEMO EXPOSURE TO DOXORUBICINE. IT WAS REPORTED THAT THE DEVICE WAS IN USE AN HOUR WHEN A DROPLET WAS NOTED AND THERAPY WAS HALTED. THE SET UP WAS A PIGGYBACK AND THERE WERE NO ISSUES NOTED DURING INITIAL SET-UP/PRIMING. THERE IS PATIENT INVOLVEMENT, AND ALTHOUGH THERE WAS A REPORT OF A DELAY IN THERAPY, THERE WAS NO ADVERSE EVENT AND NO ONE WAS HARMED AS A RESULT OF THE REPORTED EVENT. THIS REPORT REFLECTS THE FIRST OF FIVE EVENTS REPORTED.
Patient problems: Chemical Exposure; No Clinical Signs, Symptoms or Conditions
MAUDE report 11407683 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K131549. One submission often covers many models, so check the product and lot details in each record.
- Z-3159-2026 · May 12, 2026 · Open, ClassifiedOncology sets with drip chambers
- Z-3161-2026 · May 12, 2026 · Open, ClassifiedIV Sets with drip chambers
- Z-2210-2026 · Mar 24, 2026 · Open, ClassifiedOncology Kit w/60" (152 cm) Appx 2.2 ml, Smallbore Ext Set w/ChemoLock Port, Clamp, Anti-Siphon Valve, Spiros; ChemoLock; Syringe Transfer Set w/MicroClave, ChemoLock Port, REF: CL
- Z-0328-2026 · Sep 8, 2025 · Open, ClassifiedChemoLock Bag Spike, 01 units REF: CL-10-10
- Z-0337-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical Oncology Transfer Kit w/ChemoClave and ChemoLock Port; Spiros w/Red Cap; ChemoLock Port REF: CL4138
- Z-0348-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Closed Vial Spike w/Skirt, 5 Units REF: CL-80S-5
- Z-0360-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical 7.5" (19 cm) Appx 1.5 ml, Ext Set w/ChemoLock" Port, Clamp, Graduated Adapter REF: CL3967
- Z-0330-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock" Port, Bulk, Non-Sterile REF: CL2100-NS
- Z-0336-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical Oncology Kit w/ChemoLock, ChemoLock Port REF: CL4136
- Z-0359-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical 31" (79 cm) Appx 3.4 ml, Admin Set w/20 Drop Integrated ChemoLock Drip Chamber, Spiros", Purple Cap, Hanger REF: CL3951
- Z-0357-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Port w/Spiros, Red Cap REF: CL-35
- Z-0356-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical Syringe Transfer Set w/MicroClave, ChemoLock Port REF: CL-34
- Z-0346-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Closed Vial Spike REF: CL-80
- Z-0334-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical Oncology Kit w/31" (79 cm) 20 Drop Admin Set w/Integrated ChemoLock" Port Drip Chamber, Spiros"; ChemoLock"; ChemoLock" Universal Vented Vial Spike; Bag Hanger REF: C
- Z-0343-2026 · Sep 8, 2025 · Open, ClassifiedICU Medical ChemoLock Universal Vented Vial Spike REF: CL-70
…and 45 more.
Other Closed antineoplastic and hazardous drug reconstitution and transfer system devices
- BD PhaSeal 515003BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall183 reports
- BD PhaSeal 515056BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall159 reports
- BD PhaSeal Optima 515070BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall154 reports
- Alaris 10012241-0500BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall138 reports
- BD PhaSeal 515005BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall128 reports
- ICU Medical CL3011Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls26 reports
- BD PhaSeal Optima 515052BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall114 reports
- ICU Medical CL3511Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls6 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page